Hemochromatosis and fatty liver disease: Building evidence for insulin resistance in bottlenose dolphins (Tursiops Truncatus)

Journal of Zoo and Wildlife Medicine

Volumn 43, Issue SUPPL. 3, 2012, Pages

  Venn Watson, Stephanie ^a   Benham, Celeste ^a   Carlin, Kevin ^a   DeRienzo, Damian ^b   St Leger, Judy ^c  

^a NATIONAL MARINE MAMMAL FOUNDATION   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c SeaWorld San Diego   (United States)

Author keywords

Bottlenose dolphin; fatty liver disease; hemochromatosis; hemosiderosis; hepatic lipidosis; hepatitis; Tursiops truncatus

Indexed keywords

ANIMAL; ANIMAL DISEASE; BOTTLENOSE DOLPHIN; CONFERENCE PAPER; FATTY LIVER; HEMOCHROMATOSIS; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; KUPFFER CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; RISK FACTOR;

ANIMALS; BOTTLE-NOSED DOLPHIN; FATTY LIVER; HEMOCHROMATOSIS; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; KUPFFER CELLS; RISK FACTORS;

EID: 84866249131     PISSN: 10427260     EISSN: None     Source Type: Journal    
DOI: 10.1638/2011-0146.1     Document Type: Conference Paper

References (47)

1. Alberti, K. G. M., P. Zimmet, and J. Shaw, for the IDF Epidemiology Task Force. 2005. The metabolic syndrome-a new worldwide definition. Lancet 366: 1059-1062.
2. Aquilar-Martinez, P., J. F. Schved, and P. Brissot. 2005. The evaluation of hyperferritinemia: an updated strategy based on advances in detecting genetic abnormalities. Am. J. Gastroenterol. 100: 1185-1194.
3. Batts, K. P. 2007. Iron overload syndromes and the liver. Mod. Pathol. 20: S31-S39.
4. Bobe G., J. W. Young, and D. C. Beitz. 2004. Pathology, etiology, prevention of fatty liver in dairy cows. J. Dairy Sci. 87: 3105-3124.
5. Boden, G. 2006. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr. Diabetes Rep. 6: 177-181.
6. Bonar, C. J., J. G. Trupkiewicz, B. Toddes, and A. H. Lewandowski. 2006. Iron storage disease in tapirs. J. Zoo Wildl. Med. 37:49-52.
7. Browning, J. D., L. S. Szczepaniak, R. Dobbins, P. Nuremberg, J. D. Horton, J. C. Cohen, S. M. Grundy, and H. H. Hobbs. 2004. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 40: 1387-1395.
8. Carr, D. B., K. M. Utzschneider, R. L. Hull, K. Kodama, B. M. Retzlaff, J. D. Brunzell, J. B. Shofer, B. E. Fish, R. H. Knopp, and S. E. Kahn. 2004. Intraabdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53: 2087-2094.
9. Casanova-Esteban, P., N. Guiral, E. Andres, C. Gonzalvo, R. Mateo-Gallego, P. Giraldo, J. A. Paramo, and F. Civeira. 2010. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis. Metabolism 60: 830-834.
10. Cebra, C. K., F. B. Garry, D. M. Getzy, and M. J. Fettman. 1997. Hepatic lipidosis in anorectic, lactating Holstein cattle: a retrospective study of serum biochemical abnormalities. J. Vet. Intern. Med. 11: 231-237.
11. Center, S. A., M. A. Crawford, L. Guida, H. N. Erb, and J. King. 1993. A retrospective study of 77 cats with severe hepatic lipidosis: 1975-1990. J. Vet. Intern. Med. 7: 349-359.
12. Choudhury, J., and A. J. Sanyal. 2004. Clinical aspects of fatty liver disease. Semin. Liver Dis. 4: 349-362.
13. Deugnier, Y. M., O. Loreal, B. Turlin, D. Guyader, H. Jouanolle, R. Moirand, C. Jacquetlinet, and P. Brissot. 1992. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their biochemical correlations. Gastroenterology 102: 2050-2059.
14. Dimski, D. S. 1997. Feline hepatic lipidosis. Sem. Vet. Med. Surg. 12: 28-33.
15. Farina, L. L., D. J. Heard, D. M. LeBlanc, J. O. Hall, G. Stevens, J. F. Wellehan, and C. J. Detrisac. 2005. Iron storage disease in captive Egyptian fruit bats (Rousettus aegyptiacus): relationship of blood iron parameters to hepatic iron concentrations and hepatic histopathology. J. Zoo Wildl. Med. 36: 212-221.
16. Feder, J. N., A. Gnrike, W. Thomas, Z. Tsuchihashi, D. A. Ruddy, A. Basava, F. Dormishian, R. J. Domingo, M. C. Ellis, A. Fullan, L. M. Hinton, N. L. Jones, B. E. Kimmel, G. S. Kronmal, P. Lauer, V. K. Less, D. B. Loeb, F. A. Mapa, E. McClelland, N. C. Meyer, G. A. Mintier, N. Moeller, T. Moore, E. Morikang, C. E. Prass, L. Quinatant, S. M. Starnes, R. C. Schatzman, K. J. Brunke, D. T. Drayna, N. J. Risch, R. R. Bacon, and R. K. Wolff. 1996. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat. Gen. 13: 399-408.
17. Ferrannini, E., S. M. Haffner, B. S. Mitchell, and M. P. Stern. 1991. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 34: 416-422.
18. Ford, E. S., W. H. Giles, and W. H. Dietz. 2002. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. J. Am. Med. Assoc. 287: 356-359.
19. Gonzales J., K. Benirschke, P. Saltman, J. Roberts, and P. T. Robinson. 1984. Hemosiderosis in lemurs. Zoo Biol. 3: 255-265.
20. Grundy, S. M. 1999. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am. J. Cardiol. 83: 25-29.
21. Grundy, S. M., J. I. Cleeman, S. R. Daniels, D. A. Donato, R. H. Eckel, B. A. Franklin, D. J. Gordon, R. M. Krauss, P. J. Savage, S. C. Smith, J. A. Spertus, and F. Costa. 2005. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752.
22. Gustat, J., S. R. Srinivasan, A. Elkasabany, and G. S. Berenson. 2002. Relation of self-rated measures of physical activity to multiple risk factors of insulin resistance syndrome in young adults: the Bogalusa Heart Study. J. Clin. Epidemiol. 55: 997-1006.
23. House, J K., B. P. Smith, J. Maas, V. M. Lane, B. C. Anderson, T. W. Graham, and M. V. Pino. 1994. Hemochromatosis in Salers cattle. J. Vet. Intern. Med. 8: 105-111
24. Innis, S. M., and H. V. Kuhnlein. 1987. The fatty acid composition of Northern-Canadian marine and terrestrial mammals. Acta Med. Scand. 222: 105-109.
25. Johnson, S. P., S. Venn-Watson, C. E. Cassle, E. D. Jensen, C. R. Smith, and S. H. Ridgway. 2009. Use of phlebotomy treatment in Atlantic bottlenose dolphins with iron overload. J. Am. Vet. Med. Assoc. 235: 194-200.
26. Kaji, K., Y. Nakanuma, M. Sasaki, M. Unoura, K. Kobayashi, and A. Nonomura. 1995. Hemosiderin deposition in portal endothelial cells: a novel hepatic hemosiderosis frequent in chronic viral hepatitis B and C. Hum. Pathol. 26: 1080-1085.
27. Kock, N., C. Foggin, M. D. Kock, and R. Kock. 1992. Hemosiderosis in the black rhinoceros (Diceros bicornis): a comparison of free ranging and recently captured with translocated and captive animals. J. Zoo Wildl. Med. 23: 230-234.
28. Leevy, C. M. 1962. Fatty liver: a study of 270 patients with biopsy proven fatty liver and a review of the literature. Medicine 41: 249-278.
29. Mateo-Gallego, R., M. Solanas-Barca, E. Burillo, A. Cenarro, I. Marques-Lopes, and F. Civeira. 2010. Iron deposits and dietary patterns in familial combined hyperlipidemia and familial hypertriglyceridemia. J. Physiol. Biochem. 66: 229-236.
30. Matteoni, C. A., Z. M. Younossi, T. Gramlich, N. Boparai, Y. C. Liu, and A. J. McCollough. 1999. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413-1419.
31. Mazzaro, L. M., J. L. Dunn, D. J. St. Aubin, G. A. Andrews, and P. S. Chavey. 2004. Serum indices of body stores of iron in northern fur seals (Callorhinus ursinus) and their relationship to hemochromatosis. Zoo Biol. 23: 205-218.
32. Mendler M. H., B. Turlin, R. Moirand, A. M. Jouanolle, T. Sapey, D. Guyader, J. Y. le Gall, P. Brissot, V. David, and Y. Deugnier. 1999. Insulin resistance-associated hepatic iron overload. Gastroenterology 117: 1155-1163.
33. Miller, J. C. B., and S. Colagiuri. 1994. The carnivore connection: dietary carbohydrate in the evolution of NIDDM. Diabetologia 37: 1280-1286.
34. Mogg, T. D., and J. E. Palmer. 1995. Hyperlipidemia, hyperlipemia, and hepatic lipidosis in American miniature horses: 23 cases (1990-1994). J. Am. Vet. Med. Assoc. 207: 604-607.
35. Pietrangelo, A. 2007. Non-HFE hemochromatosis. Hepatology 39: 21-29.
36. Reaven, G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
37. Sheppard, C., and E. Dierenfeld. 2002. Iron storage disease in birds: speculation on etiology and implications for captive husbandry. J. Avian Med. Surg. 16: 192-197.
38. Solanas-Barca, M., R. Mateo-Gallego, P. Calmarza, E. Jarauta, A. M. Bea, A. Cenarro, and F. Civeiera. 2009. Mutations in HFE causing hemochromatosis are associated with primary hypertriglyceridemia. Endocr. Care 94: 4391-4397.
39. Szymariska, R., and M. Schmidt-Pospula. 1979. Studies of liver's reticuloendothelial cells by Tadeusz Browicz and Karl Kupffer. A historical outline. Arch. Hist. Med. 42: 331-336.
40. Venn-Watson, S., K. Carlin, and S. Ridgway. 2011. Dolphins as animal models for type 2 diabetes: Sustained, postprandial hyperglycemia and hyperinsulinemia. Gen. Comp. Endocrinol. 170: 193-199.
41. Venn-Watson, S., E. D. Jensen, and S. H. Ridgway. 2007. Effects of age and sex on clinicopathologic reference ranges in a healthy managed Atlantic bottlenose dolphin population. J. Am. Vet. Med. Assoc. 23: 596-601.
42. Venn-Watson, S., and S. H. Ridgway. 2007. Big brains and blood glucose: common ground for diabetes mellitus in humans and healthy dolphins. Comp. Med. 57: 390-395.
43. Venn-Watson, S., C. R. Smith, R. Daniels, and F. Townsend. 2010. Clinical relevance of urate nephrolithiasis in bottlenose dolphins (Tursiops truncatus) Dis. Aquat. Org. 89: 167-177.
44. Venn-Watson, S., C. R. Smith, F. Gomez, and E. D. Jensen. 2011. Physiology of aging among healthy, older bottlenose dolphins (Tursiops truncatus): comparisons with aging humans. J. Comp. Physiol. B. 181: 667-680.
45. Venn-Watson, S., C. R. Smith, and E. Jensen. 2008. Clinical relevance of elevated transaminases in a bottlenose dolphin (Tursiops truncatus) population. J. Wildl. Dis. 44: 318-330.
46. Wrede, C. E., R. Buettner, L. C. Bollheimer, J. Scholmerich, K. D. Palitzsch, and C. Hellerbrand. 2006. Association between serum ferritin and the insulin resistance syndrome in a representative population. Eur. J. Endocrinol. 154: 333-340.
47. Younossi, Z. M., T. Gramlich, C. A. Matteoni, N. Boparai, and A. J. McCollough. 2004. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin. Gastroenterol. Hepatol. 2: 262-265.